comprehensive -WSS

comprehensive

author：knowledge 2025-09-29 01:36:05 - browse：6826

After months of vigorous deliberations, I’m thrilled to announce our 2023 STATUS List — the definitive roster of leaders in health, medicine, and the life sciences whose work over the past year has advanced those fields.

There were, of course, many contenders to choose from. For this second annual list, we’ve selected just 46 — an homage to the number of chromosomes in human DNA. Many are well-known as changemakers; others are largely unheralded heroes. They are CEOs, philanthropists, government officials, and health advocates. All have compelling stories to tell.

Our editorial team painstakingly researched and identified hundreds of finalists. In winnowing down the list, judges placed special emphasis on people who have sought to help others and build community in these often-divisive times. One note: Our news coverage is independent of this list, and we remain committed to tough-minded reporting on the people and institutions shaping life sciences.

While I have your attention, I want to point you to some of our most talked-about exclusive stories in recent days: A new STAT investigation exposes how Medicare Advantage plans use algorithms to cut off care for seniors in need, and we took a closer look at how a Medicare Advantage business is strangling one of its first funders. We’re aggressively reporting on the consequences for biotech of the Silicon Valley Bank collapse.

And over the coming months, in our series “The Obesity Revolution,” we’ll explore a class of obesity drugs that is transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years.

For full access to our exclusive reporting, please consider purchasing a STAT+ subscription. Get 15% off an annual subscription by using promo code STAT15 when you check out.

As always, please reach out to me with feedback. I’m at [email protected].

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： European regulators recommend Amylyx's ALS drug be rejected

leisure time

WSS

Covid's long

Newly revealed memo details efforts to keep Trump in power following election loss

Peter Marks talks Operation Warp Speed for Rare Diseases

Newly revealed memo details efforts to keep Trump in power following election loss

Genentech weighs delaying cancer therapy after drug pricing law

Cancer cells are shown to suck energy source from immune cells

leisure time

comprehensive

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

A revolution in caring for preterm infants

New air purifier tech could be key to improving indoor air quality

Medicare to cover more brain scans related to Alzheimer’s drugs

BioMarin wins approval for gene therapy to treat hemophilia A

Researchers CRISPR chickens in bid to protect them from bird flu

Affirmative action in medical school literally saved lives

White House drug shortages task force keeps mum with Congress

BioMarin wins approval for gene therapy to treat hemophilia A

Cancer cells are shown to suck energy source from immune cells

hotspot

Peter Marks talks Operation Warp Speed for Rare Diseases

Medicare to cover more brain scans related to Alzheimer’s drugs

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

How doctors and nurses shape Google's AI

Target recalls 2.2 million additional candles due to laceration, burn hazards

Better Therapeutics data on benefit with GLP

Wikipedia

leisure time

focus

hotspot